摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2-(2,6-dichlorophenyl)acrylate | 1203555-33-2

中文名称
——
中文别名
——
英文名称
methyl 2-(2,6-dichlorophenyl)acrylate
英文别名
methyl 2-(2,6-dichlorophenyl)prop-2-enoate
methyl 2-(2,6-dichlorophenyl)acrylate化学式
CAS
1203555-33-2
化学式
C10H8Cl2O2
mdl
——
分子量
231.078
InChiKey
AUMSGBUAXMTMTE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    47-48 °C
  • 沸点:
    327.3±32.0 °C(Predicted)
  • 密度:
    1.289±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 2-(2,6-dichlorophenyl)acrylatesodium methylate 、 sodium hydride 作用下, 以 甲醇二甲基亚砜 、 mineral oil 为溶剂, 反应 5.0h, 生成 4-amino-6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7(8H)-one
    参考文献:
    名称:
    4-Amino-2-arylamino-6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7-(8H)-ones as BCR kinase inhibitors for B lymphoid malignancies
    摘要:
    A new family of 4-aminopyrido[2,3-d]pyrimidines active against non-Hodgkin's lymphomas (NHLs) is described. Among these compounds, 19 inhibits the most upstream tyrosine kinases in the B cell receptor (BCR) signaling pathway which are involved in the mature B cell neoplasms. Thus, 19 showed anti-proliferative activity at 24 h and 48 h against a panel of 20 NHLs cell lines with GI(50) ranging from 1.3 to 6.91 mu M at 24 h, and 1.4-7.2 mu M at 48 h, being this effect related to a significant (20-90%) inhibition of the phosphorylation of the BCR-related kinases Btk, Syk, and Lyn. Most importantly, 19 was able to induce a 63% reduction in Rec-1 cell proliferation, which was significantly greater than the 31% and 3% blockade of proliferation observed after cell treatment with R406, a Syk inhibitor, and ibrutinib, a Btk inhibitor, respectively. The computational blind docking and ligand binding within the pockets of Btk, Syk and Lyn kinases showed that compound 19 presents the same kind of interactions of described cocrystallized inhibitors. (C) 2014 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2014.09.018
  • 作为产物:
    描述:
    聚合甲醛2,6-二氯苯乙酸甲酯potassium carbonatecalcium oxide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 16.0h, 以94%的产率得到methyl 2-(2,6-dichlorophenyl)acrylate
    参考文献:
    名称:
    3,3-二甲氧基丙烷腈对2-芳基丙烯酸酯的不寻常迈克尔加成:通往4-未取代的5,6-二氢吡啶并[2,3- d ]嘧啶的便捷途径
    摘要:
    2-芳基取代的丙烯酸酯和3,3-二甲氧基丙腈之间的不寻常的迈克尔加成,这取决于反应温度(分别为60或-78°C),导致生成4-甲氧基亚甲基取代的4-氰基丁酸酯或描述了4-二甲氧基甲基4-氰基丁酸酯。在微波辐射下用胍系统处理后,这些化合物可随后转化为4-未取代的吡啶并[2,3- d ]嘧啶。
    DOI:
    10.1021/jo902345r
点击查看最新优质反应信息

文献信息

  • Design, synthesis and biological evaluation of pyrido[2,3-d]pyrimidin-7-(8H)-ones as HCV inhibitors
    作者:Marta Camarasa、Raimon Puig de la Bellacasa、Àlex L. González、Raül Ondoño、Roger Estrada、Sandra Franco、Roger Badia、José Esté、Miguel Ángel Martínez、Jordi Teixidó、Bonaventura Clotet、José I. Borrell
    DOI:10.1016/j.ejmech.2016.03.055
    日期:2016.6
    design and selection of a combinatorial library of pyrido[2,3-d]pyrimidin-7(8H)-ones (4) has allowed the synthesis of 121 compounds, using known and new synthetic methodologies, and the evaluation of the inhibitory activity against hepatitis C virus (HCV) genotype 1b replicon. Among these compounds, 214,10} and 242,10} presented very high activities [EC50 = 0.027 μM (CC50 = 5.3 μM) and EC50 = 0.034 μM
    吡啶并[2,3 - d ]嘧啶-7(8 H)-ones(4)的组合文库的设计和选择已允许使用已知的和新的合成方法合成121种化合物,并对其抑制性进行评估抗丙型肝炎病毒(HCV)基因型1b复制子的活性。在这些化合物中,21 4,10 }和24 2,10 }表现出非常高的活性[分别为EC 50  = 0.027μM(CC 50  = 5.3μM)和EC 50  = 0.034μM(CC 50  = 13.5μM)]和高选择性指数196和397。这些值类似于EC 50索非布韦(2)(0.048μM )使用相似的方法学方法和相同的病毒亚型报道。21 4,10 }和24 2,10 }是通过比sofosbuvir短的合成路线而获得的,而24 2,10 }是非手性的,与sofosbuvir具有4个立体生成中心相反。计算机研究表明21 4,10 }和24 2,10 }通过变构位点结合抑制NS5B聚合酶。
  • 4-Amino-2-arylamino-6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7-(8H)-ones as BCR kinase inhibitors for B lymphoid malignancies
    作者:Raimon Puig de la Bellacasa、Gaël Roué、Patricia Balsas、Patricia Pérez-Galán、Jordi Teixidó、Dolors Colomer、José I. Borrell
    DOI:10.1016/j.ejmech.2014.09.018
    日期:2014.10
    A new family of 4-aminopyrido[2,3-d]pyrimidines active against non-Hodgkin's lymphomas (NHLs) is described. Among these compounds, 19 inhibits the most upstream tyrosine kinases in the B cell receptor (BCR) signaling pathway which are involved in the mature B cell neoplasms. Thus, 19 showed anti-proliferative activity at 24 h and 48 h against a panel of 20 NHLs cell lines with GI(50) ranging from 1.3 to 6.91 mu M at 24 h, and 1.4-7.2 mu M at 48 h, being this effect related to a significant (20-90%) inhibition of the phosphorylation of the BCR-related kinases Btk, Syk, and Lyn. Most importantly, 19 was able to induce a 63% reduction in Rec-1 cell proliferation, which was significantly greater than the 31% and 3% blockade of proliferation observed after cell treatment with R406, a Syk inhibitor, and ibrutinib, a Btk inhibitor, respectively. The computational blind docking and ligand binding within the pockets of Btk, Syk and Lyn kinases showed that compound 19 presents the same kind of interactions of described cocrystallized inhibitors. (C) 2014 Elsevier Masson SAS. All rights reserved.
  • An Unusual Michael Addition of 3,3-Dimethoxypropanenitrile to 2-Aryl Acrylates: A Convenient Route to 4-Unsubstituted 5,6-Dihydropyrido[2,3-<i>d</i>]pyrimidines
    作者:Xavier Berzosa、Xavier Bellatriu、Jordi Teixidó、José I. Borrell
    DOI:10.1021/jo902345r
    日期:2010.1.15
    An unusual Michael addition between 2-aryl-substituted acrylates and 3,3-dimethoxypropanenitrile which leads, depending on the reaction temperature (60 or −78 °C, respectively), to a 4-methoxymethylene-substituted 4-cyanobutyric ester or to a 4-dimethoxymethyl 4-cyanobutyric ester is described. These compounds can be subsequently converted to 4-unsubstituted pyrido[2,3-d]pyrimidines upon treatment
    2-芳基取代的丙烯酸酯和3,3-二甲氧基丙腈之间的不寻常的迈克尔加成,这取决于反应温度(分别为60或-78°C),导致生成4-甲氧基亚甲基取代的4-氰基丁酸酯或描述了4-二甲氧基甲基4-氰基丁酸酯。在微波辐射下用胍系统处理后,这些化合物可随后转化为4-未取代的吡啶并[2,3- d ]嘧啶。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐